Expression changes in BRCA1-deficient breast cancer PDX models treated with PARP-inhibitors.. PARP-inhibitors applied to BRCA1-null PDX models
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
BRCA1 deficiencies cause breast, ovarian and other cancers, and render tumours hypersensitive to PARP-inhibitors. To understand resistance mechanisms, we conducted explored expression changes in BRCA1-deficient breast cancer PDX models treated with PARP-inhibitors.
创建时间：
2018-06-01
